A 49-year-old white woman was referred by an outside eye provider to the glaucoma service at Tufts Medical Center for ...
Important insights into the mechanisms behind Fuchs endothelial corneal dystrophy (FECD), a common cause of age-related visual loss, have been revealed in a new study led by UCL researchers.
EyeYon Medical, a global leader in innovative corneal implant solutions, is proud to announce that Dr. Ofer Daphna, the ...
In this cross section of a cornea in a person with Fuchs' dystrophy, the green rectangles represent endothelial cells. The magenta dots are outgrowths of Descemet's membrane known as guttae.
Approximately 4% of people aged 40 years and older have corneal endothelial disease/dystrophy (CED) affecting the back of the cornea, and corneal transplantation is the only treatment option for ...
Background Descemet's Stripping with Automated Endothelial Keratoplasty (DSAEK ... Immediately postoperatively, corneal graft displacement and peripheral corneal edema which remained stable ...
In 2022, doctors in Japan performed a transplant of iPS cell-derived corneal endothelial cells iPS cell derived-corneal endothelial cell transplants are injected and take about 20 minutes In Japan ...
Hosted on MSN11mon
Aurion doses first subject in Phase I/II corneal oedema trial in Canadaa new cell therapy aimed at treating corneal oedema due to corneal endothelial dysfunction. The therapy combines neltependocel, allogeneic human corneal endothelial cells (CECs) with Rho ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results